The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways

By Meng Jin   Zhang Hai-Hua   Zhou Chun-Xiang   Li Chen   Zhang Feng   Mei Qi-Bing  

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 384-388

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax

By              

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1523-1530

Spandidos Publications

Access to resources Recommend Favorite

Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341

By Fang Yong   Hu Yi   Wu Peng   Wang Beibei   Tian Yuan   Xia Xi   Zhang Qinghua   Chen Tong   Jiang Xuefeng   Ma Quanfu   Xu Gang   Wang Shixuan   Zhou Jianfeng   Ma Ding   Meng Li  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 247-252

Informa Healthcare

Access to resources Recommend Favorite

Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 304-310

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells

By            

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1293-1300

Spandidos Publications

Access to resources Recommend Favorite